These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 11119511

  • 21. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT, Cunha-Neto E, Goldberg AC, Kalil J, de Jesus AR, Carvalho EM, Correa-Oliveira R, Oliveira SC.
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [Abstract] [Full Text] [Related]

  • 22. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
    Siles-Lucas M, Uribe N, López-Abán J, Vicente B, Orfao A, Nogal-Ruiz JJ, Feliciano AS, Muro A.
    Vaccine; 2007 Oct 10; 25(41):7217-23. PubMed ID: 17707955
    [Abstract] [Full Text] [Related]

  • 23. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
    King CL, Malhotra I, Jia X.
    Exp Parasitol; 1996 Nov 10; 84(2):245-52. PubMed ID: 8932774
    [Abstract] [Full Text] [Related]

  • 24. Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel.
    Feldmeier H, Gastl GA, Poggensee U, Daffalla AA, Nogueira-Queiroz JA, Capron A, Peter HH.
    Scand J Immunol; 1988 Aug 10; 28(2):147-55. PubMed ID: 3137653
    [Abstract] [Full Text] [Related]

  • 25. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum.
    Argiro L, Henri S, Dessein H, Kouriba B, Dessein AJ, Bourgois A.
    Vaccine; 2000 Apr 03; 18(19):2033-8. PubMed ID: 10706966
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.
    Acta Trop; 2013 Nov 03; 128(2):292-302. PubMed ID: 23022016
    [Abstract] [Full Text] [Related]

  • 31. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
    Abdel Aziz N, Tallima H, Hafez EA, El Ridi R.
    Scand J Immunol; 2016 Feb 03; 83(2):128-38. PubMed ID: 26603950
    [Abstract] [Full Text] [Related]

  • 32. Acquired immunity and epidemiology of Schistosoma haematobium.
    Woolhouse ME, Taylor P, Matanhire D, Chandiwana SK.
    Nature; 1991 Jun 27; 351(6329):757-9. PubMed ID: 1905786
    [Abstract] [Full Text] [Related]

  • 33. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
    Grzych JM, Grezel D, Xu CB, Neyrinck JL, Capron M, Ouma JH, Butterworth AE, Capron A.
    J Immunol; 1993 Jan 15; 150(2):527-35. PubMed ID: 8419485
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cellular and humoral immune responses to recombinant Smp17.7 Schistosoma mansoni antigen.
    Al-Sherbiny MM, Galal IF, Karim AM, Ashour AA, Saad AH.
    J Egypt Soc Parasitol; 2003 Dec 15; 33(3):925-46. PubMed ID: 14708863
    [Abstract] [Full Text] [Related]

  • 36. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
    Hernandez HJ, Wang Y, Stadecker MJ.
    J Immunol; 1997 May 15; 158(10):4832-7. PubMed ID: 9144498
    [Abstract] [Full Text] [Related]

  • 37. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment.
    Webster M, Fulford AJ, Braun G, Ouma JH, Kariuki HC, Havercroft JC, Gachuhi K, Sturrock RF, Butterworth AE, Dunne DW.
    Infect Immun; 1996 Oct 15; 64(10):4042-6. PubMed ID: 8926066
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM, Silva MR, Santos IG, Silva GA, Gomes DA, Goes AM.
    Immunol Lett; 2011 Dec 30; 141(1):123-33. PubMed ID: 21945176
    [Abstract] [Full Text] [Related]

  • 40. Differential production in vitro of antigen specific IgG1, IgG3 and IgA: a study in Schistosoma haematobium infected individuals.
    Béniguel L, Diallo TO, Remoué F, Williams DL, Cognasse F, Charrier-Mze N, N'Diaye AA, Perraut R, Capron M, Riveau G, Garraud O.
    Parasite Immunol; 2003 Jan 30; 25(1):39-44. PubMed ID: 12753436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.